1. Controlling the unfolded protein response-mediated life and death decisions in cancer
   Marion Maurel et al, 2015, Seminars in Cancer Biology CrossRef
2. Preferential cytotoxicity of bortezomib toward highly malignant human liposarcoma cells via suppression of MDR1 expression and function
   Yamei Hu et al, 2015, Toxicology and Applied Pharmacology CrossRef
3. Targeting autophagy in multiple myeloma
   Zhuang Yun et al, 2017, Leukemia Research CrossRef
4. Multiple myeloma proteostasis can be targeted via translation initiation factor eIF4E
   VICTORIA ZISMANOV et al, 2015 CrossRef
5. Targeting the integrated networks of aggresome formation, proteasome, and autophagy potentiates ER stress‑mediated cell death in multiple myeloma cells.
   Shota Moriya et al, 2015, Int. J. Oncol. CrossRef
6. EGFR-independent autophagy induction with gefitinib and enhancement of its cytotoxic effect by targeting autophagy with clarithromycin in non-small cell lung cancer cells.
   Shohei Sugita et al, 2015, Biochem. Biophys. Res. Commun. CrossRef
7. The cyclin-dependent kinase 4/6 inhibitor, abemaciclib, exerts dose-dependent cytostatic and cytocidal effects and induces autophagy in multiple myeloma cells.
   Noriyoshi Iriyama, 0 CrossRef
8. Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma
   Caterina Musolino et al, 2017, Mediators of Inflammation CrossRef
9. Protective effects of agomelatine on testicular damage caused by bortezomib
   N Akaras et al, 2017, Biotechnic & Histochemistry CrossRef
10. Targeting bortezomib-induced aggresome formation using vinorelbine enhances the cytotoxic effect along with ER stress loading in breast cancer cell lines
    Kana Miyahara et al, 2016 CrossRef
11. Macrolides sensitize EGFR-TKI-induced non-apoptotic cell death via blocking autophagy flux in pancreatic cancer cell lines
    SHUNTARO MUKAI et al, 2016 CrossRef
12. A novel combination of bortezomib, lenalidomide, and clarithromycin produced stringent complete response in refractory multiple myeloma complicated with diabetes mellitus – clinical significance and possible mechanisms: a case report
    Nobuo Takemori et al, 2018, J Med Case Reports CrossRef
13. Designing an effective drug combination for ER stress loading in cancer therapy using a real-time monitoring system
    Hiromi Kazama et al, 2018, Biochemical and Biophysical Research Communications CrossRef
14. Azithromycin enhances anticancer activity of TRAIL by inhibiting autophagy and up-regulating the protein levels of DR4/5 in colon cancer cells in vitro and in vivo
    Xinran Qiao et al, 2018, Cancer Commun CrossRef
15. A randomized placebo-controlled phase II study of clarithromycin or placebo combined with VCD induction therapy prior to high-dose melphalan with stem cell support in patients with newly diagnosed multiple myeloma
    Henrik Gregersen et al, 2018, Exp Hematol Oncol CrossRef
16. Airway epithelial cells exposed to wildfire smoke extract exhibit dysregulated autophagy and barrier dysfunction consistent with COPD
    Eugene Roscioli et al, 2018, Respir Res CrossRef
17. Characterization of aggregate/aggresome structures formed by polyhedrin of Bombyx mori nucleopolyhedrovirus
    Zhong-Jian Guo et al, 2015, Sci Rep CrossRef
18. Mechanisms of proteasome inhibitor-induced cytotoxicity in malignant glioma
    Panagiotis J. Vlachostergios et al, 2013, Cell Biol Toxicol CrossRef
19. Combined treatment with SAHA, bortezomib, and clarithromycin for concomitant targeting of aggresome formation and intracellular proteolytic pathways enhances ER stress-mediated cell death in breast cancer cells
    Seiichiro Komatsu et al, 2013, Biochemical and Biophysical Research Communications CrossRef
20. Carfilzomib with immunomodulatory drugs for the treatment of newly diagnosed multiple myeloma
    Ola Landgren et al, 2019, Leukemia CrossRef
21. Novel estradiol analogue induces apoptosis and autophagy in esophageal carcinoma cells
    Elize Wolmarans et al, 2014 CrossRef
22. Azithromycin: Mechanisms of action and their relevance for clinical applications
    Michael J. Parnham et al, 2014, Pharmacology & Therapeutics CrossRef
23. The endoplasmic reticulum stress markers GRP78 and CHOP predict disease-free survival and responsiveness to chemotherapy in breast cancer
    Yi-Zi Zheng et al, 2014, Breast Cancer Res Treat CrossRef
24. Therapeutic targeting of autophagy in cancer. Part II: Pharmacological modulation of treatment-induced autophagy
    Anika Nagelkerke et al, 2015, Seminars in Cancer Biology CrossRef
25. null
    Nathan G. Dolloff, 2015 CrossRef
26. Mechanical Stretch Induces Apoptosis Regulator TRB3 in Cultured Cardiomyocytes and Volume-Overloaded Heart
    Wen-Pin Cheng et al, 2015, PLoS ONE CrossRef
27. Endoplasmic reticulum stress and autophagy participate in apoptosis induced by bortezomib in cervical cancer cells
    Yudi Zhang et al, 2016, Biotechnol Lett CrossRef
28. Carfilzomib combined with suberanilohydroxamic acid (SAHA) synergistically promotes endoplasmic reticulum stress in non-small cell lung cancer cell lines
    Neale T. Hanke et al, 2016, J Cancer Res Clin Oncol CrossRef
29. Drugs acting on homeostasis: challenging cancer cell adaptation
    Maria Moschovi et al, 2015, Expert Review of Anticancer Therapy CrossRef
30. Physical basis for the ofloxacin-induced acceleration of lysozyme aggregation and polymorphism in amyloid fibrils
    Shivani A. Muthu et al, 2016, Archives of Biochemistry and Biophysics CrossRef
31. Progressive refractory light chain amyloidosis and multiple myeloma patients are responsive to the addition of clarithromycin to IMiD based therapy
    Adir Shaulov et al, 2017, Am. J. Hematol. CrossRef
32. Mitochondrial proteins NIP-SNAP-1 and -2 are a target for the immunomodulatory activity of clarithromycin, which involves NF-κB-mediated cytokine production
    Soh Yamamoto et al, 2017, Biochemical and Biophysical Research Communications CrossRef
33. Macrolide Antibiotics Exhibit Cytotoxic Effect under Amino Acid-Depleted Culture Condition by Blocking Autophagy Flux in Head and Neck Squamous Cell Carcinoma Cell Lines
    Kazuhiro Hirasawa et al, 2016, PLoS ONE CrossRef
34. TP53INP2-related basal autophagy is involved in the growth and malignant progression in human liposarcoma cells
    Yamei Hu et al, 2017, Biomedicine & Pharmacotherapy CrossRef
35. Clarithromycin inhibits autophagy in colorectal cancer by regulating the hERG1 potassium channel interaction with PI3K
    Giulia Petroni et al, 2020, Cell Death Dis CrossRef
36. Comparison of autophagy inducibility in various tyrosine kinase inhibitors and their enhanced cytotoxicity via inhibition of autophagy in cancer cells in combined treatment with azithromycin
    Hideki Tanaka et al, 2020, Biochemistry and Biophysics Reports CrossRef
37. Combination of an Autophagy Inducer and an Autophagy Inhibitor: A Smarter Strategy Emerging in Cancer Therapy.
    Ting Liu et al, 2020, Front Pharmacol CrossRef
38. Mechanisms of Action of Autophagy Modulators Dissected by Quantitative Systems Pharmacology Analysis
    Qingya Shi et al, 2020, IJMS CrossRef
39. The 26S proteasome is a multifaceted target for anti-cancer therapies
    Tatyana A Grigoreva et al, 2015, Oncotarget CrossRef
40. Role of autophagy in regulation of cancer cell death/apoptosis during anti-cancer therapy: focus on autophagy flux blockade.
    Nirmala Tilija Pun et al, 2020, Arch Pharm Res CrossRef
41. Canonical and Noncanonical Autophagy as Potential Targets for COVID-19
    Melissa Bello-Perez et al, 2020, Cells CrossRef
42. Amino acid starvation culture condition sensitizes EGFR-expressing cancer cell lines to gefitinib-mediated cytotoxicity by inducing atypical necroptosis
    Yu Saito et al, 2018, Int J Oncol CrossRef
43. Mycobacterium abscessus Clearance by Neutrophils Is Independent of Autophagy
    Kerstin Pohl et al, 2020, Infect Immun CrossRef
44. The immuno-oncological challenge of COVID-19
    Lisa Derosa et al, 2020, Nat Cancer CrossRef
45. Can endolysosomal deacidification and inhibition of autophagy prevent severe COVID-19?
    Gerwyn Morris et al, 2020, Life Sciences CrossRef
46. Oral cysteamine as an adjunct treatment in cystic fibrosis pulmonary exacerbations: An exploratory randomized clinical trial
    Graham Devereux et al, 2020, PLoS ONE CrossRef
47. Immunomodulatory Effects of Azithromycin Revisited: Potential Applications to COVID-19
    Vincent J. Venditto et al, 2021, Front. Immunol. CrossRef
48. OPALS: A New Osimertinib Adjunctive Treatment of Lung Adenocarcinoma or Glioblastoma Using Five Repurposed Drugs
    Richard E. Kast et al, 2021, Cells CrossRef
49. Azithromycin enhances the cytotoxicity of DNA‐damaging drugs via lysosomal membrane permeabilization in lung cancer cells
    Kazutoshi Toriyama et al, 2021, Cancer Sci CrossRef
50. Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know?
    Christina Pfab et al, 2021, Cancers CrossRef
51. Induction of synergistic non‑apoptotic cell death by simultaneously targeting proteasomes with bortezomib and histone deacetylase 6 with ricolinostat in head and neck tumor cells
    Kazuhiro Hattori et al, 2021, Oncol Lett CrossRef
52. null
    Ahood Khalid et al, 2021 CrossRef
53. ClC5 Decreases the Sensitivity of Multiple Myeloma Cells to Bortezomib via Promoting Prosurvival Autophagy.
    Huimin Zhang et al, 2018, Oncol Res CrossRef
54. Secondary Immunodeficiency in Hematological Malignancies: Focus on Multiple Myeloma and Chronic Lymphocytic Leukemia.
    Alessandro Allegra et al, 2021, Front Immunol CrossRef
55. Pitavastatin Induces Cancer Cell Apoptosis by Blocking Autophagy Flux
    Nirmala Tilija Pun et al, 2022, Front. Pharmacol. CrossRef
56. Delivering macrolide antibiotics to heal a broken heart – And other inflammatory conditions
    Vincent J. Venditto et al, 2022, Advanced Drug Delivery Reviews CrossRef
57. nGlobal Effect of COVID-19 Pandemic on Cancer Patients and its treatment: A Systematic Review
    Mohammad Ali et al, 2022, Clinical Complementary Medicine and Pharmacology CrossRef
58. Inhibition of autolysosomes by repurposing drugs as a promising therapeutic strategy for the treatment of cancers
    Abdul Alim Al-Bari, 2022, All Life CrossRef
59. Clarithromycin Synergistically Enhances Thalidomide Cytotoxicity in Myeloma Cells
    Xu-Hua Qiu et al, 2016, Acta Haematol CrossRef
60. Drug Repositioning for the Treatment of Hematologic Disease: Limits, Challenges and Future Perspectives
    Alessandro Allegra et al, 2021, CMC CrossRef
61. The role of goblet cells and mucus in intestinal homeostasis
    Jenny K. Gustafsson et al, 2022, Nat Rev Gastroenterol Hepatol CrossRef
62. Responses of zebrafish (Danio rerio) cells to antibiotic erythromycin stress at the subcellular levels
    Meng Yang et al, 2022, Science of The Total Environment CrossRef
63. Azithromycin, a potent autophagy inhibitor for cancer therapy, perturbs cytoskeletal protein dynamics
    Naoharu Takano et al, 2023, Br J Cancer CrossRef
64. Immunomodulatory role of azithromycin: Potential applications to radiation-induced lung injury
    Yujie Yan et al, 2023, Front. Oncol. CrossRef
65. Autophagy: A Potential Therapeutic Target to Tackle Drug Resistance in Multiple Myeloma
    Hamed Bashiri et al, 2023, IJMS CrossRef
66. A mini‐review on anticancer‐related properties of azithromycin and its potential activities in overcoming the challenges of glioblastoma
    Siti Nazihahasma Hassan et al, 2023, Fundamemntal Clinical Pharma CrossRef
67. Photocatalytic degradation of four emerging antibiotic contaminants and toxicity assessment in wastewater: A comprehensive study
    Manisha Sharma et al, 2023, Environmental Research CrossRef
68. Clarithromycin overcomes stromal cell-mediated drug resistance against proteasome inhibitors in myeloma cells via autophagy flux blockage leading to high NOXA expression
    Shota Moriya et al, 2023, PLoS ONE CrossRef
69. null
    Mitsuko Kondo, 2024 CrossRef
70. null
    Masahiro Shinoda, 2024 CrossRef
71. In vivo screening for toxicity-modulating drug interactions identifies antagonism that protects against ototoxicity in zebrafish
    Ethan Bustad et al, 2024, Front. Pharmacol. CrossRef